Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands

Published:2011-10 Issue:20 Volume:19 Page:6135-6142
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Vardanyan Ruben,Kumirov Vlad K.,Nichol Gary S.,Davis Peg,Liktor-Busa Erika,Rankin David,Varga Eva,Vanderah Todd,Porreca Frank,Lai Josephine,Hruby Victor J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference27 articles.

1. The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety

2. Improving Metabolic Stability by Glycosylation: Bifunctional Peptide Derivatives That Are Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists

3. The Importance of Micelle-Bound States for the Bioactivities of Bifunctional Peptide Derivatives for δ/μ Opioid Receptor Agonists and Neurokinin 1 Receptor Antagonists

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach;Medicinal Research Reviews;2024-05-15

2. Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics;International Journal of Molecular Sciences;2022-03-02

3. Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships;International Journal of Molecular Sciences;2022-01-21

4. Carboxyl-fentanyl detection using optical fibre grating-based sensors functionalised with molecularly imprinted nanoparticles;Biosensors and Bioelectronics;2021-04

5. Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?;Pharmacology & Therapeutics;2019-04